Commentary in Hematology/Oncology on "Liquid biopsy can direct use of EGFR rechallenge in metastatic colorectal cancer," a study presented at the 2021 annual American Society for Clinical Oncology (ASCO) meeting.

Commentary in Hematology/Oncology on "Alrizomadlin may restore efficacy of PD-1 blockade in immunotherapy-resistant tumors," a study presented at the 2021 annual American Society for Clinical Oncology (ASCO) meeting.